{"filing":{"accession_number":"0001493152-26-036648","cik":"0001752828","ticker":"CELUW","company_name":"Celularity Inc","form":"8-K","filing_date":"2026-08-07","report_date":"2026-08-05","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226036648/form8-k.htm"},"events":[{"id":25136,"run_id":22806,"accession_number":"0001493152-26-036648","anchor_item_number":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the termination of Rick Gonzalez, the Company's Chief Commercial Officer, effective immediately on August 5, 2026. This is a clear executive departure under Item 5.02, as the principal disclosed action is a named officer leaving his role. The CCO position is material to investor assessment of the company's commercial strategy and execution.","company_name":"Celularity Inc","ticker":"CELUW","filing_date":"2026-08-07","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":25889,"accession_number":"0001493152-26-036648","item_number":null,"item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the termination of Rick Gonzalez, the Company's Chief Commercial Officer, effective immediately on August 5, 2026. This is a clear executive departure under Item 5.02, as the principal disclosed action is a named officer leaving his role. The CCO position is material to investor assessment of the company's commercial strategy and execution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T00:32:04.662645+00:00","company_name":"Celularity Inc","ticker":"CELUW","filing_date":"2026-08-07"}]}